• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mixed; Target Posts Downbeat Earnings

    5/22/24 9:55:04 AM ET
    $AKTS
    $BDRX
    $BNED
    $BZFD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKTS alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones index falling around 20 points on Wednesday.

    Following the market opening Wednesday, the Dow traded down 0.05% to 39,853.86 while the NASDAQ rose 0.04% to 16,839.94. The S&P 500 also fell, dropping, 0.03% to 5,319.84.

    Check This Out: Top 5 Industrials Stocks That May Explode This Quarter

    Leading and Lagging Sectors

    Industrials shares rose by 0.2% on Wednesday.

    In trading on Wednesday, energy shares fell by 0.9%.

    Top Headline

    Target Corp (NYSE:TGT) reported weaker-than-expected first-quarter earnings.

    The company reported a first-quarter FY24 sales decline of 3.1% year-on-year to $24.531 billion, beating the analyst consensus estimate of $24.521 billion. Comparable sales declined 3.7% in the first quarter. Adjusted EPS of $2.03 missed the analyst consensus estimate of $2.06.

    Equities Trading UP
                           

    • Akoustis Technologies, Inc. (NASDAQ:AKTS) shares shot up 222% to $0.4474 after the company reportedly floated the probability of bankruptcy after losing a lawsuit against Qorvo.
    • Shares of Barnes & Noble Education, Inc. (NYSE:BNED) got a boost, surging 104% to $1.10 on continued volatility. Greenhaven last week said it continues to explore a possible transaction with the company.
    • BuzzFeed, Inc. (NASDAQ:BZFD) shares were also up, gaining 67% to $4.15 after Vivek Ramaswamy disclosed a 7.7% stake in the company.

    Equities Trading DOWN

    • Edible Garden AG Incorporated (NASDAQ:EDBL) shares dropped 56% to $1.91 after the company announced the pricing of a $6 million public offering.
    • Shares of Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) were down 34% to $1.53 after the company announced $7 million of gross proceeds from warrant exercises.
    • Yatsen Holding Limited (NYSE:YSG) was down, falling 23% to $3.50 after the company announced downbeat quarterly results.

    Also Check This Out: Qualcomm, American Express And 2 Other Stocks Insiders Are Selling

    Commodities

    In commodity news, oil traded down 0.8% to $78.03 while gold traded down 0.5% at $2,413.50.

    Silver traded down 0.2% to $32.025 on Wednesday, while copper fell 3.5% to $4.93.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 fell 0.4%, Germany's DAX fell 0.2% and France's CAC 40 dipped 0.6%. Spain's IBEX 35 Index fell 0.1%, while London's FTSE 100 fell 0.6%.

    The annual inflation rate in the UK fell to 2.3% in April from 3.2% in March, while producer prices rose 1.1% year-over-year in April.

    Passenger car registrations in the European Union jumped 13.7% year-over-year to 914 thousand units in April.

    Asia Pacific Markets

    Asian markets closed mixed on Wednesday, with Japan's Nikkei falling 0.85%, China's Composite Index gaining 0.02%, Hong Kong's Hang Seng Index falling 0.13% and India's S&P BSE Sensex gaining 0.2%.

    Japanese trade deficit rose to JPY 462,50 billion in April compared to a year-ago gap of JPY 429,79 billion. Japan’s core machinery orders climbed 2.9% month-over-month to 913 billion yen in March.

    Economics

    U.S. mortgage applications rose by 1.9% from the prior week in the period ending May 17, compared to a 0.5% gain in the prior week.

    Now Read This: Jim Cramer: This Industrial Stock Is Doing ‘Very Well’; Here’s His Take On Palantir

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $BDRX
    $BNED
    $BZFD

    CompanyDatePrice TargetRatingAnalyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$30.00Overweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$34.00Buy
    BofA Securities
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$31.00Outperform
    Leerink Partners
    Aktis Oncology Inc.
    $AKTS
    2/3/2026Buy
    TD Cowen
    Target Corporation
    $TGT
    1/27/2026Underperform → Peer Perform
    Wolfe Research
    Target Corporation
    $TGT
    1/8/2026Hold
    Deutsche Bank
    BuzzFeed Inc.
    $BZFD
    11/21/2025$1.00Buy → Hold
    Craig Hallum
    Target Corporation
    $TGT
    10/15/2025Neutral
    BTIG Research
    More analyst ratings

    $AKTS
    $BDRX
    $BNED
    $BZFD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Foley Todd converted options into 4,002,533 shares and bought $4,191,660 worth of shares (232,870 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:20:21 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Mpm Bioventures 2018, L.P. converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:19:26 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Gadicke Ansbert converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:17:54 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $BZFD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rothstein Adam converted options into 101,337 shares, increasing direct ownership by 14% to 841,038 units (SEC Form 4)

    4 - BuzzFeed, Inc. (0001828972) (Issuer)

    2/3/26 5:25:53 PM ET
    $BZFD
    Telecommunications Equipment
    Consumer Discretionary

    Director Naidrich Michael Joseph was granted 131,810 shares (SEC Form 4)

    4 - Edible Garden AG Inc (0001809750) (Issuer)

    1/16/26 4:31:26 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form 3 filed by new insider Naidrich Michael Joseph

    3 - Edible Garden AG Inc (0001809750) (Issuer)

    1/16/26 4:30:36 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $AKTS
    $BDRX
    $BNED
    $BZFD
    SEC Filings

    View All

    Target Corporation filed SEC Form 8-K: Leadership Update

    8-K - TARGET CORP (0000027419) (Filer)

    2/5/26 11:31:04 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Edible Garden AG Incorporated filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Edible Garden AG Inc (0001809750) (Filer)

    2/5/26 7:30:46 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form 424B3 filed by Biodexa Pharmaceuticals plc American Depositary Shs

    424B3 - Biodexa Pharmaceuticals Plc (0001643918) (Filer)

    2/4/26 8:51:45 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $BZFD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edible Garden to Participate in ECRM's Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, February 10–12, 2026

    BELVIDERE, NJ, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that it will participate in ECRM's Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, taking place February 10–12, 2026, at the Hyatt Regency Chicago O'Hare in Rosemont, Illinois. ECRM's Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session brings together leading brands and top retail buyers through curated, one-on-one meetings designed to drive meaningful product discovery and comme

    2/5/26 8:09:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Target Celebrates 10th Year of 1 Million Volunteer Hours, Deepens Community Vitalization Efforts for 2026 as Part of Company's Longstanding Commitment to Communities

    Target team members contributed 1 million volunteer hours to their communities in 2025, marking the 10th time the company has achieved this annual goalTarget celebrates the milestone with a planned investment of $1 million to its Bullseye Builds with Community Program2025 volunteer efforts reached communities in all 50 states, part of the company's year-round commitment that also includes giving 5% of company profits* to communities in products, cash and through the Target FoundationCompany activates local resources in its home state to support community needsMINNEAPOLIS, Feb. 4, 2026 /PRNewswire/ -- Target Corporation (NYSE:TGT) today announced that it contributed 1 million volunteer hours

    2/4/26 1:00:00 PM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

    February 4, 2026 Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST Novel Mechanism of Action Shown to be Effective in TKI Resistant PDX Models Cardiff, UK – February 4, 2026 – Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with unmet medical needs, today announced the closing of an exclusive license with Otsuka Pharmaceutical Co., Ltd (Otsuka) for OPB-171775. a novel molecular glue intended to be developed for the treatment of gastrointestinal stromal tumours (GIST). The compound also has the potential to be useful

    2/4/26 8:30:00 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $BZFD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst initiated coverage on Aktis Oncology with a new price target

    Analyst initiated coverage of Aktis Oncology with a rating of Overweight and set a new price target of $30.00

    2/3/26 6:54:43 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BofA Securities initiated coverage on Aktis Oncology with a new price target

    BofA Securities initiated coverage of Aktis Oncology with a rating of Buy and set a new price target of $34.00

    2/3/26 6:54:33 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Leerink Partners initiated coverage on Aktis Oncology with a new price target

    Leerink Partners initiated coverage of Aktis Oncology with a rating of Outperform and set a new price target of $31.00

    2/3/26 6:54:33 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $BZFD
    Leadership Updates

    Live Leadership Updates

    View All

    Target Appoints Former Nike and HanesBrands Executives to Board of Directors

    John Hoke, former Chief Innovation Officer at NIKE, Inc., will join the Board on March 1 and serve on the Governance & Sustainability and the Compensation & Human Capital Management committeesSteve Bratspies, former CEO of HanesBrands, will join the Board on April 1 and serve on the Audit & Risk and the Infrastructure & Finance committeesThe appointments come as Target prepares for its next chapter of growth under incoming CEO Michael FiddelkeMINNEAPOLIS, Jan. 22, 2026 /PRNewswire/ -- Target Corporation (NYSE:TGT) announced today the election of two accomplished retail leaders to its Board of Directors: John Hoke, III, former chief innovation officer at NIKE, Inc., and Steve Bratspies, forme

    1/22/26 11:00:00 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Edible Garden Appoints Board Member Matthew McConnell as Executive Vice President, Strategic Partnerships

    BELVIDERE, NJ, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that Matthew McConnell, a member of the Company's Board of Directors, has joined Edible Garden's senior leadership team full time as Executive Vice President Strategic Partnerships, effective immediately. In this role, Mr. McConnell will be responsible for advancing the Company's strategic initiatives, strengthening relationships with investors and partners, and supporting long-term growth objectives across key channels.

    1/9/26 7:30:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary

    January 05, 2026 Biodexa Pharmaceuticals PLC Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is delighted to announce the promotion of Fiona Sharp to Chief Financial Officer and Company Secretary along with her election to the Board of Directors of the Company with immediate effect. Ms Sharp is a senior finance professional having joined the Company as Group Financial Controller in December 2019. During her tenure, she has consistentl

    1/5/26 8:30:00 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $BDRX
    $BNED
    $BZFD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/20/24 11:56:39 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Edible Garden AG Incorporated

    SC 13G/A - Edible Garden AG Inc (0001809750) (Subject)

    11/14/24 7:24:20 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Barnes & Noble Education Inc

    SC 13G/A - Barnes & Noble Education, Inc. (0001634117) (Subject)

    11/14/24 6:34:18 PM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    $AKTS
    $BDRX
    $BNED
    $BZFD
    Financials

    Live finance-specific insights

    View All

    BuzzFeed, Inc. to Release Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 12, 2026

    Founder and CEO Jonah Peretti and CFO Matt Omer will host a conference call to discuss the results at 5:00 PM ET / 2:00 PM PT BuzzFeed, Inc. (NASDAQ:BZFD) today announced it will release its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, after the market closes. BuzzFeed Founder and CEO Jonah Peretti and CFO Matt Omer will host a conference call to discuss the results at 5:00 PM ET / 2:00 PM PT. The financial results conference call will be available at investors.buzzfeed.com under the ‘News and Events' section. A replay will be available at the same location following the call. To participate in the conference call, interested parties must register in

    1/22/26 4:15:00 PM ET
    $BZFD
    Telecommunications Equipment
    Consumer Discretionary

    Target Corporation Declares Regular Quarterly Dividend

    MINNEAPOLIS, Jan. 22, 2026 /PRNewswire/ -- The board of directors of Target Corporation (NYSE:TGT) has declared a quarterly dividend of $1.14 per common share.  The dividend is payable March 1, 2026 to shareholders of record at the close of business February 11, 2026.  The first quarter dividend will be the company's 234th consecutive dividend paid since October 1967 when the company became publicly held. About TargetMinneapolis-based Target Corporation (NYSE:TGT) serves guests at nearly 2,000 stores and at Target.com, with the purpose of helping all families discover the joy of everyday life. Since 1946, Target has given 5% of its profit to communities, which today equals millions of dollar

    1/22/26 6:30:00 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Target Corporation Reports Third Quarter Earnings

    MINNEAPOLIS, Nov. 19, 2025 /PRNewswire/ -- Target Corporation (NYSE:TGT) today announced its third quarter 2025 financial results. Third quarter net sales were $25.3 billion, 1.5 percent lower than 2024.Digital comparable sales grew 2.4 percent, led by more than 35% growth in same-day delivery powered by Target Circle 360. Food & Beverage and Hardlines ("Fun 101") delivered comparable sales growth in the quarter, offset by continued softness across the broader discretionary portfolio.Non-merchandise sales grew nearly 18 percent with Roundel, membership and marketplace revenues all growing double digits.Third quarter GAAP EPS was $1.51 compared with $1.85 last year. Adjusted EPS1, which exclu

    11/19/25 6:30:00 AM ET
    $TGT
    Department/Specialty Retail Stores
    Consumer Discretionary